Kamil P Grela

Mr. Kamil P Grela

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Julita KulbackaJulita Kulbacka
Julita Kulbacka
NRNina Rembiałkowska
Nina Rembiałkowska
ASAnna Maria Szewczyk
Anna Maria Szewczyk
HMHelena Moreira
Helena Moreira
ASAnna Szyjka
Anna Szyjka
Vitalij NovickijVitalij Novickij
Vitalij Novickij
(1) Background: Calcium electroporation (CaEP) is based on the application of electrical pulses to permeabilize cells (electroporation) and allow cytotoxic doses of calcium to enter the cell. (2) Methods: In this work, we have used doxorubicin-resistant (DX) and non-resistant models of human breast cancer (MCF-7/DX, MCF-7/WT) and colon cancer cells (LoVo, LoVo/DX), and investigated the susceptibility of the cells to extracellular Ca2+ and electric fields in the 20 ns–900 ns pulse duration range. (3) Results: We have observed that colon cancer cells were less susceptible to PEF than breast cancer cells. An extracellular Ca2+ (2 mM) with PEF was more disruptive for DX-resistant cells. The expression of glycoprotein P (MDR1, P-gp) as a drug resistance marker was detected by the immunofluorescent (CLSM) method and rhodamine-123 efflux as an MDR1 activity. MDR1 expression was not significantly modified by nanosecond electroporation in multidrug-resistant cells, but a combination with calcium ions significantly inhibited MDR1 activity and cell viability. (4) Conclusions: We believe that PEF with calcium ions can reduce drug resistance by inhibiting drug efflux activity. This phenomenon of MDR mechanism disruption seems promising in anticancer protocols.

27 November 2021 in Materials
Verified
Journal Article
Open access
PDF file
KGKamil P Grela
Kamil P Grela
DMDominik M. Marciniak
Dominik M. Marciniak
BKBozena Karolewicz
Bozena Karolewicz
This article covers the design and evaluation of a novel drug vehicle: a thermosensitive, injectable, high-oil-content (50% w/w) emulgel providing a controlled release of lipophilic pharmaceuticals. Different vegetable (castor, canola, olive, peanut, grapeseed, linseed), mineral (paraffin) and semisynthetic (isopropyl myristate, oleic acid) oils were screened for ibuprofen (IBU) solubility and for their capacity for high-shear emulsification in a 17% (w/w) aqueous solution of poloxamer 407. Chosen emulgels were subject to a rheological evaluation, a syringeability test (TA.XT texture analyser; 2 mL syringe; 18 G, 20 G and 22 G needles) and a drug release study (48 h; cellulose membrane; 0.05 mol/L phosphate buffer at pH 7.4). Castor oil turned out to be an optimal component for IBU incorporation. Blank and drug-loaded castor oil emulgels were susceptible to administration via a syringe and needle, with the absolute injection force not exceeding 3 kg (29.4 N). The drug release test revealed dose-dependent, quasi-linear kinetics, with up to 44 h of controlled, steady, linear release. The results indicate the significant potential of high-oil-content, oil-in-water thermosensitive emulgel formulations as vehicles for the controlled release of lipophilic APIs.

1 June 2019
Verified
Journal Article
Closed access
KGKamil P Grela
Kamil P Grela
IBI Baginska
I Baginska
JBJ. Burak
J. Burak
DMD. M. Marciniak
D. M. Marciniak
BKBozena Karolewicz
Bozena Karolewicz

14 June 2021 in Farmacja Polska
Verified
Journal Article
Open access
Radosław BalwierzRadosław Balwierz
Radosław Balwierz
KJKarol Jasiński
Karol Jasiński
MOMarcin Osowski
Marcin Osowski
KGKamil P Grela
Kamil P Grela
Ewa Natalia Karpęcka-GałkaEwa Natalia Karpęcka-Gałka
Ewa Natalia Karpęcka-Gałka
USUrszula Skotnicka-Graca
Urszula Skotnicka-Graca